http://bmj.com/cgi/content/full/325/7359/311
| Home | Help | Search/Archive | Feedback | Table of Contents |
|
||||||||
 Collections
under which this article appears: Menopause
(incl HRT) Other
Cardiovascular Medicine Other
Endocrinology Other
Epidemiology Cancer:
breast Ischaemic
heart disease |
Debbie A Lawlor
Department of Social Medicine, University of Bristol, Bristol BS8 2PR
Correspondence to: D A Lawlor D.A.Lawlor@bristol.ac.uk
The sex difference in mortality from coronary heart disease decreases with
increasing age, suggesting a protective effect of oestrogen in
premenopausal women. This decrease is, however, the result of a
deceleration in death rates in men, with no change in rates in women
around the age of menopause.1 The age specific
rate of breast cancer
a
condition associated with endogenous oestrogendoes
show a change around the age of menopause among women in the United
States.2 The relatively low rates of coronary
heart disease in premenopausal women may make it difficult to detect
an effect of the menopause.3 Rates of
breast cancer among Japanese women are low. If low rates of coronary
heart disease around the time of the menopause explain the lack of an
effect of the menopause on age related trends then no effect of the
menopause on breast cancer trends among Japanese women might be
expected.
 |
Methods and results |
|---|
 Top  Methods and
results  Comment References
|
|---|
We obtained data on age specific mortality from coronary heart disease (ICD-9 (international classification of diseases, 9th revision): 410-414) for women and men and from breast cancer (ICD-9: 174) for women in England and Wales from the Office for National Statistics and in Japan from the World Health Organization. We calculated five year aggregate rates for each country (1994-8 for England and Wales and 1993-7 for Japan) and plotted them on a semilogarithmic scale.
Coronary heart disease mortality in women from both countries increased with age, and in both countries the death rate in men decelerated at older ages, reducing the magnitude of the sex difference (figure). We found no inflection in age specific mortality from coronary heart disease in women around the age of menopause in either England and Wales or Japan. In contrast, mortality from breast cancer began to decelerate around the time of the menopause in both groups.
|
| |
Comment |
|---|
|
Top Methods and
results Comment
References
|
|---|
Mortality from breast cancer in Japanese women is about half that from coronary heart disease in women in England and Wales at ages 45-54; it is thus unlikely that the low mortality from coronary heart disease makes detection of a menopause effect difficult. The inflection in breast cancer mortality occurs over a narrow age range, suggesting that if effects of menopausal oestrogen on coronary heart disease occurred they too should operate over a similar range and be observable. However, coronary heart disease is associated with several environmental risk factors, and if the effect of oestrogen on risk of coronary heart disease is small relative to other risk factors then any effect of the menopause may be masked.
Witteman et al argue that age related trends in coronary heart disease mortality are not inconsistent with an effect of the menopause.4 They used simulation models based on levels of risk of coronary heart disease in men to estimate age related trends in "women who never experience a menopause."4 Such analyses are unrealistic and unhelpful.
Work on the aetiology of coronary heart disease in women has been dominated
by the idea that oestrogen plays an important part and is responsible
for the sex difference at younger ages. The implications of this are
that higher rates of coronary heart disease in men are seen as
inevitable and that postmenopausal hormone replacement therapy has
become the mainstay of coronary heart disease prevention in women. We
conclude that environmental factors are the most important
determinants of coronary heart disease in women and men and of the
difference in coronary heart disease rates between women and men.5
| |
Acknowledgments |
|---|
Contributors: All authors conceived the idea for the study. DAL undertook the analysis and wrote the first draft of the paper. All authors contributed to the final report. DAL will act as guarantor.
| |
Footnotes |
|---|
Funding: DAL is an MRC research training fellow and is funded by the Medical Research Council. Views expressed are those of the authors.
Competing interests: None declared.
| |
References |
|---|
|
Top Methods and
results Comment References
|
|---|
| 1. | Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet 1998; 351: 1425-1427[Medline]. |
| 2. | Tracy RE. Sex difference in coronary disease: two opposing views. J Chronic Dis 1966; 19: 1245-1251[Medline]. |
| 3. | Meilahn E. Sex steroid hormonal influences on coronary artery disease. In: Ness RB, Kuller LH, eds. Health and disease among women. Oxford: Oxford University Press, 1999:155-182. |
| 4. | Witteman JCM, Moerman CJ, Westendorp ICD. Myth of the menopause paradox. Lancet 1998; 352: 407. |
| 5. | Lawlor DA, Ebrahim S, Davey Smith G. Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality. BMJ 2001; 323: 541-545[Abstract/Full Text]. |
(Accepted 12 February 2002)
|
||||||||
|
Collections
under which this article appears:Menopause
(incl HRT) Other
Cardiovascular Medicine Other
Endocrinology Other
Epidemiology Cancer:
breast Ischaemic
heart disease |
| Home | Help | Search/Archive | Feedback | Table of Contents |
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
